IUR Fundamental Analysis - KAP AG

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to IUR. IUR was compared to 16 industry peers in the Industrial Conglomerates industry. Both the profitability and financial health of IUR have multiple concerns. IUR is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year IUR has reported negative net income.

In the past year IUR had a positive cash flow from operations.

IUR had negative earnings in 4 of the past 5 years.

Each year in the past 5 years IUR had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -17.76%, IUR is doing worse than 93.75% of the companies in the same industry.

IUR's Return On Equity of -38.65% is on the low side compared to the rest of the industry. IUR is outperformed by 81.25% of its industry peers.

		Industry Rank	Sector Rank
ROA	-17.76%
ROE	-38.65%
ROIC	N/A

ROA(3y)-6.1%

ROA(5y)-1.54%

ROE(3y)-13.28%

ROE(5y)-4.05%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

IUR has a better Gross Margin (59.04%) than 75.00% of its industry peers.

In the last couple of years the Gross Margin of IUR has grown nicely.

IUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	59.04%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.1%

GM growth 5Y2.29%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

IUR does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for IUR remains at a similar level compared to 1 year ago.

The number of shares outstanding for IUR remains at a similar level compared to 5 years ago.

IUR has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.06, we must say that IUR is in the distress zone and has some risk of bankruptcy.

IUR's Altman-Z score of 1.06 is on the low side compared to the rest of the industry. IUR is outperformed by 87.50% of its industry peers.

A Debt/Equity ratio of 0.44 indicates that IUR is not too dependend on debt financing.

IUR has a Debt to Equity ratio of 0.44. This is in the better half of the industry: IUR outperforms 75.00% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.44
Debt/FCF	N/A
Altman-Z	1.06

ROIC/WACCN/A

WACC6.99%

2.3 Liquidity

A Current Ratio of 1.38 indicates that IUR should not have too much problems paying its short term obligations.

Looking at the Current ratio, with a value of 1.38, IUR is doing worse than 62.50% of the companies in the same industry.

A Quick Ratio of 0.81 indicates that IUR may have some problems paying its short term obligations.

IUR's Quick ratio of 0.81 is on the low side compared to the rest of the industry. IUR is outperformed by 68.75% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.38
Quick Ratio	0.81

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

IUR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14575.00%.

The Revenue for IUR has decreased by -11.59% in the past year. This is quite bad

The Revenue has been decreasing by -6.64% on average over the past years.

EPS 1Y (TTM)-14575%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-13000%

Revenue 1Y (TTM)-11.59%

Revenue growth 3Y-9.94%

Revenue growth 5Y-6.64%

Sales Q2Q%-70.56%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IUR. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IUR indicates a rather cheap valuation: IUR is cheaper than 100.00% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	1.14

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.87%, IUR is a good candidate for dividend investing.

The stock price of IUR dropped by -78.40% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.

Compared to an average industry Dividend Yield of 3.18, IUR pays a better dividend. On top of this IUR pays more dividend than 100.00% of the companies listed in the same industry.

Compared to an average S&P500 Dividend Yield of 1.94, IUR pays a better dividend.

		Industry Rank	Sector Rank
Dividend Yield	10.87%

5.2 History

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

DP0%

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

KAP AG

FRA:IUR (1/5/2026, 7:00:00 PM)

1.76

-0.09 (-4.86%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryIndustrial Conglomerates

Earnings (Last)08-29 2025-08-29

Earnings (Next)N/A N/A

Inst Owners0.24%

Inst Owner ChangeN/A

Ins Owners25.7%

Ins Owner ChangeN/A

Market Cap13.68M

Revenue(TTM)252.50M

Net Income(TTM)-45.66M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	10.87%

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.05
P/FCF	N/A
P/OCF	0.82
P/B	0.12
P/tB	0.13
EV/EBITDA	1.14

EPS(TTM)-5.87

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-1.25

FCFYN/A

OCF(TTM)2.16

OCFY122.49%

SpS32.5

BVpS15.2

TBVpS13.12

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-17.76%
ROE	-38.65%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	59.04%
FCFM	N/A

ROA(3y)-6.1%

ROA(5y)-1.54%

ROE(3y)-13.28%

ROE(5y)-4.05%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.1%

GM growth 5Y2.29%

F-Score4

Asset Turnover0.98

Health

		Industry Rank	Sector Rank
Debt/Equity	0.44
Debt/FCF	N/A
Debt/EBITDA	1.08
Cap/Depr	42.95%
Cap/Sales	10.48%
Interest Coverage	N/A
Cash Conversion	34.76%
Profit Quality	N/A
Current Ratio	1.38
Quick Ratio	0.81
Altman-Z	1.06

F-Score4

WACC6.99%

ROIC/WACCN/A

Cap/Depr(3y)65.33%

Cap/Depr(5y)78.67%

Cap/Sales(3y)10.8%

Cap/Sales(5y)9.68%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-14575%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-13000%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-11.59%

Revenue growth 3Y-9.94%

Revenue growth 5Y-6.64%

Sales Q2Q%-70.56%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y59.65%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y62.76%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-9.53%

OCF growth 3Y26.34%

OCF growth 5Y-13.95%

KAP AG / IUR.DE FAQ

What is the ChartMill fundamental rating of KAP AG (IUR.DE) stock?

ChartMill assigns a fundamental rating of 2 / 10 to IUR.DE.

What is the valuation status for IUR stock?

ChartMill assigns a valuation rating of 1 / 10 to KAP AG (IUR.DE). This can be considered as Overvalued.

How profitable is KAP AG (IUR.DE) stock?

KAP AG (IUR.DE) has a profitability rating of 2 / 10.

How financially healthy is KAP AG?

The financial health rating of KAP AG (IUR.DE) is 2 / 10.

KAP AG (IUR.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens

KAP AG / IUR.DE FAQ

What is the ChartMill fundamental rating of KAP AG (IUR.DE) stock?

What is the valuation status for IUR stock?

How profitable is KAP AG (IUR.DE) stock?

How financially healthy is KAP AG?